A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles privately for source information, while also obtaining discount codes.
Thriving Trade on Messaging Platforms
Separately, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Sellers promote the substance there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to users administering products of uncertain source.
Some professionals stated the popularity for the experimental drug could be connected to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer regulations, risking penalties, legal action or prison.
Platform Response and Content Elimination
According to the social media company, the platform has removed problematic material and prohibited associated keywords and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.
Online Trading Operations
Research also discovered communities with up to nine thousand members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, populated with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at home.
After minutes of entering one group, a vendor shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, health issues or past usage.
Product Information and Pricing
Within these groups, messages display dark colored parcels with postal service stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers varying between a several days to “depends on your body”.
Service Oversight and Security Measures
A representative for Telegram said it regularly monitored dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her team has previously encountered individuals injured by self-injection from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet authorized … may expose patients to potentially significant health risks”.
